High Court bans 34 pharmaceutical companies from producing medicines
Staff Correspondent, bdnews24.com
Published: 2017-02-13 14:47:07.0 BdST Updated: 2017-02-14 02:15:50.0 BdST
Twenty pharmaceutical companies have been banned from producing all medicines and 14 others from producing antibiotics by the High Court.
The order on Monday by Justices Syed Mohammed Dastagir and Ataur Rahman Khan came after hearing of a rule issued earlier on a petition filed by the Human Rights and Peace for Bangladesh (HRPB) to stop production and marketing of substandard medicines.
The order asked the Bangladesh drug regulatory authority to regularly monitor whether these companies continued to produce and market medicines and file a report to the High Court after every four months.
HRPB counsel Manzill Murshid said that the government has already cancelled the license of 7-8 of these 34 companies.
The High Court has constituted a five-member committee to examine fresh application by those companies who have not had their license cancelled, if they agreed to abide by existing drug regulatory parameters.
The committee consists of a representative each from World Health Organisation, Bangladesh Drug Regulatory Authority, Dhaka University's Pharmacy department and the Health Ministry.
Twenty companies banned from producing all medicines
Exim Pharmaceuticals, Avert Pharma Ltd, Bikalpa Pharmaceuticals Ltd, Dolphin Pharmaceuticals Ltd, Drugland Ltd, Globe Laboratories Pvt Ltd, Jolpa Laboratories Ltd, Kafma Pharmaceuticals Ltd, Medico Pharmaceuticals Ltd, National Drug Pharma Ltd, North Bengal Pharmaceuticals Ltd, Rimo Chemicals Ltd, Rid Pharmaceuticals Ltd, Skylab Pharmaceuticals Ltd, Spark Pharmaceuticals Ltd, Star Pharmaceuticals Ltd, Shunipun Pharmaceuticals Ltd, Today Pharmaceuticals Ltd, Tropical Pharmaceuticals Ltd and Universal Pharmaceuticals Ltd
Fourteen companies banned from producing antibiotics
Ad-dwin Pharmaceutical Ltd, Alkad Laboratories Ltd, Belsen Pharmaceuticals Ltd, Bengal Drugs and Chemicals (Pharma) Ltd, Bristol Pharma Ltd, Crystal Pharmaceuticals Ltd, Indo-Bangla Pharmaceuticals Ltd, Millat Pharmaceuticals Ltd, MST Pharma and Healthcare Ltd, Orbit Pharmaceuticals Ltd, Pharmic Laboratories ltd, Phoenix Chemical Laboratory Ltd, Rasa Pharmaceuticals Ltd and Save Pharmaceuticals Ltd
Any unauthorised use or reproduction of bdnews24.com content for commercial purposes is strictly prohibited and constitutes copyright infringement liable to legal action.
- Bull market not dead as tax reform takes spotlight
- FBCCI president challenges HC order halting elections
- Trump tantrum looms on Wall Street if healthcare effort stalls
- High Court halts FBCCI elections for two months
- Asian stocks drop as fresh Trump jitters jolt risk sentiment
- Asian shares at 21-month high, dollar soft on less hawkish Fed
- Sonali Bank gets Bangladesh Bank nod to start PayPal services
- Oil drops on rising US drilling, steady OPEC supply
- Uber president Jeff Jones quits, deepening turmoil
- Unilever prepares $7.44 billion sale of food brands: newspapers
- Army para-commandos, SWAT launch assault on militant den in Sylhet's Shibbarhi
- At least one killed, 20 injured in blast near militant den being raided by army commandos
- Army commandos end assault on militant hideout in Sylhet
- Superb Tamim, gritty Shakib fire Bangladesh to crushing win over Sri Lanka
- Donald Trump greets Abdul Hamid, Sheikh Hasina on Bangladesh’s Independence Day
- One killed in blast near Dhaka airport; police rule out 'suicide attack'
- Crocodile kills man at Barguna eco-park
- Army para-commandos, SWAT, police wait for final assault at Sylhet ‘militant den’
- Bangladesh information minister backs controversial Section 57 of ICT Act
- Mashrafe urges Mustafizur to shine against Sri Lanka in Dambulla